Obesity and Insulin Resistance are Major Concerns in the Prevention and Treatment of Comorbidities

Science Press Release Distribution Services

Obesity and Insulin Resistance are Major Concerns in the Prevention and Treatment of Comorbidities

September 8, 2021 Health Research 0

For a long time, it was assumed that, while weight loss was necessary and desired, comorbidities were far more significant and required treatment, preferably with medication, even if weight loss was not a treatment objective. This disagreement causes therapy to be postponed, which then leads to overly extensive medical treatment. As a result, health-care expenses have risen to unacceptably high levels, resulting in the medicalization of individuals and a decline in patient responsibility for their own health, leaving it up to individuals to decide when their own weight is an issue that needs to be addressed. The goal of this study was to gather evidence to support a paradigm change in regards to the association between body weight and comorbidities. Insulin resistance is the root of the problem, which leads to a slew of other health issues. To ensure better tailor-made treatment for patients, this illness should be diagnosed at primary care and obesity clinics. Treatment for insulin resistance should begin as soon as possible, when comorbidities are still changeable, and include specific dietary recommendations and counselling, preferably by a nutritionist. The treatment includes an activity programme.

Author (S) Details

Elisabeth Govers
Amstelring Foundation for Primary Care, The Netherlands and Dutch Dietitians Knowledge Centre for Overweight and Obesity (KDOO), The Netherlands.

View Book :- https://stm.bookpi.org/IDHR-V2/article/view/3080

 

Leave a Reply

Your email address will not be published. Required fields are marked *